HR 1657, the Lake Winnibigoshish Land Exchange Act of 2024, authorizes a direct land swap between Big Winnie Land and Timber, LLC (BWLT) and the U.S. government. It would transfer approximately 13.8 acres of federal land in Itasca County, Minnesota, to BWLT in exchange for 38 acres of private land owned by BWLT, which would then be added to the Chippewa National Forest. The exchange requires appraisals to ensure equal value, with a cash payment adjustment if needed - though the government waives payment if the private land is valued higher. The Secretary of Agriculture must complete the transfer within 180 days of BWLT’s offer, following specific appraisal standards and finalizing legal descriptions for public review.
SRES 848 is a symbolic Senate resolution designating September 23-27, 2024, as "National Hazing Awareness Week." It does not create new laws or requirements but formally recognizes the issue of hazing in college settings. The resolution aims to raise public awareness about hazing, which directly affects college students participating in campus organizations, as highlighted by statistics showing 55% of students in extracurricular activities reported experiencing hazing. The bill encourages nationwide observance through education and prevention efforts, emphasizing that awareness should extend beyond a single week.
SRES 851 is a Senate resolution designating November 2, 2024, as National Bison Day. It encourages the American public to observe the day with ceremonies and activities to recognize bison's cultural, historical, and economic significance. The resolution highlights bison's role in Indigenous traditions, conservation efforts, and U.S. heritage, as detailed in its preamble. It does not create legal obligations but serves as a symbolic acknowledgment of bison's importance.
This bill clarifies Medicare rules to allow doctors to provide certain critical medications directly in their offices without extra administrative hurdles. It specifically amends a Medicare provision (Section 1877(b)(2) of the Social Security Act) to remove a requirement that drugs furnished in-office must follow specific administrative rules, effective May 11, 2023. The bill also directs the removal of conflicting Medicare guidance published in 2021 and 2023, which had previously restricted this practice. This change directly affects Medicare beneficiaries (seniors) and doctors' offices that supply covered medications during patient visits. It streamlines access to necessary drugs by eliminating an unnecessary barrier to in-office medication administration under Medicare.
HR 3433, the "Give Kids a Chance Act of 2024," requires pharmaceutical companies developing certain cancer drugs to conduct pediatric studies if the drugs target molecular pathways relevant to childhood cancers. It directly affects drug manufacturers submitting new applications for cancer treatments, particularly those combining previously approved adult cancer drugs or containing a single new active ingredient. The bill amends FDA regulations to mandate these pediatric investigations only when specific conditions are met, such as when a drug's molecular target is relevant to pediatric cancer growth. The FDA must issue implementing guidance within 12 months, and reports to Congress will track implementation and effectiveness starting 2 years after enactment.
This bill prohibits hospitals and transplant centers from denying organ transplants or related services to people with disabilities solely because of their disability. It requires covered entities to make reasonable modifications to policies (like considering a patient's support network for post-transplant care) and provide auxiliary aids (such as communication services or accessible health information). The law specifically prevents discrimination based on disability during evaluation, listing, and treatment, while clarifying that medical decisions must be based on individualized assessments - not disability alone. It applies to all organ transplant processes and allows individuals to file complaints with the Department of Health and Human Services or sue for violations.
HJRES 136 is a resolution seeking to block an Environmental Protection Agency (EPA) rule that would have set new emissions standards for light and medium-duty vehicles sold in 2027 and later model years. The EPA rule, published in April 2024, aimed to require vehicle manufacturers to meet stricter pollution limits for these vehicles. If passed, this resolution would cancel the rule, preventing the EPA from enforcing the new standards. It uses a congressional process that allows Congress to reject agency rules with a simple majority vote.
SRES 838 is a symbolic Senate resolution designating November 17, 2024, as "National Warrior Call Day." It aims to raise awareness about veteran and military member mental health by emphasizing the importance of peer-to-peer connections during transition from service. The resolution cites statistics showing high veteran suicide rates (33.9 per 100,000 in 2021) and encourages all Americans to reach out to veterans or active-duty personnel for support. It does not create new laws or funding but urges public engagement through "making a warrior call" to prevent isolation. This resolution directly affects public awareness and voluntary actions, not specific individuals or programs.
HR 8292, the Taxpayer Data Protection Act, increases penalties for unauthorized disclosures of taxpayer information under the Internal Revenue Code. It raises fines from $5,000 to $250,000 per violation and increases potential jail time from 5 to 10 years for those who disclose such data. The bill also specifies that if a single disclosure affects multiple taxpayers, each affected person counts as a separate violation, potentially increasing penalties. This law directly affects IRS employees and government workers handling taxpayer data, applying to disclosures made after the bill's enactment.
This bill requires states to verify the living status of Medicaid beneficiaries quarterly using the federal Death Master File, starting January 1, 2025. It directly affects Medicaid enrollees and state Medicaid programs by mandating checks to confirm beneficiaries are alive. If a state identifies a deceased enrollee, it must automatically disenroll them and stop future payments (though prior services remain covered). The law aims to prevent continued payments for deceased individuals by creating a standardized, regular verification process.
The DeOndra Dixon INCLUDE Project Act of 2024 establishes a new National Institutes of Health (NIH) research program focused on Down syndrome. It requires the NIH to study medical conditions often linked to Down syndrome - such as Alzheimer's disease, heart problems, and autoimmune disorders - to develop better treatments and improve quality of life for individuals with Down syndrome. The program must coordinate existing NIH research, expand clinical trials involving people with Down syndrome, and submit biennial reports to Congress on progress. The bill authorizes $250 million annually for fiscal years 2025-2030 to fund this initiative, supplementing but not replacing current NIH funding for Down syndrome research.
HR 6033, the SPEAK Act of 2024, creates a task force within the Department of Health and Human Services to address telehealth barriers for patients with limited English proficiency (LEP). The task force - comprising healthcare providers, tech vendors, language services, and patient advocates - will assess current obstacles and develop best practices for improving access to telehealth platforms, video interpretation, and digital patient portals. Within 90 days of each annual report, the Secretary must publish a public website sharing these best practices, including guidance on integrating interpreters and making telehealth instructions accessible. The bill directly affects LEP patients and healthcare providers who serve them, aiming to make digital health tools more usable through concrete, evidence-based recommendations.
